Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Stephen Liberles
Harvard Medical School, Department: Anatomy/cell Biology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kallyope Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Kallyope is focused on the gut-brain axis which offers an opportunity to access and influence brain centers involved in fundamental human processes. Dr. Liberles research under this grant is focused on
using Cre/loxP technology to chart the anatomy, responses, and functions of GLP1Rcontaining neurons in the vagus nerve. The vagus nerve interfaces with control of the digestive track.
Charting vagal circuits containing glucagon-like peptide 1 receptor
Therapies based on glucagon-like peptide 1 (GLP1) provide an effective strategy for treatment of type 2 diabetes and potentially other metabolic disorders such as obesity. Additional studies are needed to understand various GLP1-responsive neural circuits as understanding these circuits could facilitate development of drugs with preferred specificity, efficacy, and route of administration. This project will use molecular and genetic approaches to study the sensory biology of vagal neurons containing GLP1 receptor, determining (1) their projections throughout the body and brain, (2) the sensory stimuli they detect, and (3) their functions in normal physiology and disease.
Filed on March 27, 2017.
Tell us what you know about Stephen Liberles's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Stephen Liberles filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Stephen Liberles | Harvard Medical School | Conflict of Interest | Kallyope Inc. | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.